StockNoteStockNote
Vietnam Medical Investment - Pharmaceutical Joint Stock Company (JVC), formerly known as Vietnam Japan Medical Equipment Co., Ltd., was established in 2001. The company has officially equitized and operated under the model of a joint stock company since 2010. The company specializes in distribution, warranty and repair of modern and quality imaging equipment. The medical device business is the main activity of the Company. The company specializes in providing high-tech medical equipment such as magnetic resonance imaging (MRI), computerized tomography (CT-scanner system), X-ray system, ultrasound system (Ultrasound-scanner system), digital X-ray system, hemodialysis machine, hematology test machine, refractive taath surgery machine, cataract surgery machine... imported from Japan, Korea, Singapore. On June 21, 2011, JVC officially traded on the Ho Chi Minh City Stock Exchange (hose)
JVC currently has a market capitalization of roughly VND 326 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 6,4x is 53% below its own 5-year average (13,7x), suggesting the stock is trading cheaper than its historical norm. P/B stands at 0,5x, 51% below its multi-year average of 1,1x. Return on equity (ROE) is at 8,3%. Its debt-to-equity ratio of 0,3x is low, reflecting a conservative capital structure. In 2025, revenue grew 25% year-on-year while after-tax profit grew 24%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Unit: VND billion. Growth (%) vs. previous period.
Unit: VND billion. Year-end values; current year uses latest session.
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.